Clinical features, radiological findings and prognosis of microscopic polyangiitis with interstitial lung disease: a

Qingzhong Song1, Yajuan Liu1, Tingting Wu2

  • 1Department of Respiratory, Ningbo Zhenhai People's Hospital (Ningbo No. 7 Hospital), No. 718, Nan'er West Road, Luotuo Street, Zhenhai, Ningbo, Zhejiang, China.

BMC Pulmonary Medicine
|December 9, 2024
PubMed
Abstract

Insights

Microscopic polyangiitis with interstitial lung disease (MPA-ILD) is more common than previously thought and has a poorer prognosis. ANCA testing is crucial for ILD patients, as MPA-ILD shows distinct imaging features and reduced survival.

Area of Science:

  • Pulmonology
  • Rheumatology
  • Immunology

Background:

  • The association between interstitial lung disease (ILD) and microscopic polyangiitis (MPA) is increasingly recognized.
  • No studies have compared clinical characteristics and prognoses between MPA-ILD and ANCA-negative ILDs.

Purpose of the Study:

  • To analyze clinical characteristics and survival differences between MPA-ILD and ANCA-negative ILD patients.
  • To identify potential imaging biomarkers for MPA-ILD.

Main Methods:

  • Retrospective review of 60 MPA-ILD and 60 matched ANCA-negative ILD patients.
  • Analysis of baseline clinical information, laboratory parameters, and chest HRCT data.
  • Survival analysis comparing outcomes between the two groups.

Main Results:

  • MPA-ILD patients were older with higher CRP, ESR, and serum creatinine, and lower hemoglobin.
  • UIP pattern and oddly shaped cysts were more common in MPA-ILD.
  • MPA-ILD patients had significantly shorter survival compared to ANCA-negative ILD patients.

Conclusions:

  • MPA-ILD is not rare and warrants ANCA testing in ILD patients.
  • Oddly shaped cysts with a UIP pattern may indicate MPA-ILD.
  • Prognosis is poor for older MPA-ILD patients, especially those with diffuse alveolar hemorrhage (DAH) or acute exacerbations (AEs).

Related Concept Videos